BioSphere CE-marks embolisation EmboGold microspheres:
This article was originally published in Clinica
BioSphere Medical has gained the European go-ahead to market its EmboGold microspheres for use in general embolisation procedures, including for uterine fibroid embolisation. The EmboGold microspheres offer advantages over the firm's current flagship product, EmboSphere microspheres, as they are packaged in pre-filled syringes and are tinted to improve visibility. The EmboGold microspheres are also approved in Canada and were launched in the US in September last year.